{"id":"W4385803938","doi":"10.1016/s0140-6736(23)01554-4","title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Proteinuria; Clinical endpoint; Renal function; Internal medicine; Placebo; Nephropathy; Kidney disease; Clinical trial; Gastroenterology; Kidney; Pathology; Endocrinology; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002206205,0.001340507,0.003271954,0.0002586438,0.0003307358,0.001296852,0.0008841892,0.00195044,0.003104221],"category_scores_gemma":[0.001861246,0.0005402077,0.002791971,0.0002993243,0.001343939,0.001219044,0.0003314435,0.00360312,0.0005798891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001066547,"about_ca_system_score_gemma":0.0008568983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001696972,"about_ca_topic_score_gemma":0.002994579,"domain_scores_codex":[0.999193,0.0003830955,0.00004276355,0.000135141,0.00007194926,0.0001740821],"domain_scores_gemma":[0.9985967,0.0005443829,0.0002904703,0.0001276849,0.00007043951,0.0003702531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9735674,0.002989465,0.001176895,0.0004475749,0.001156964,0.00007397324,0.00007356324,0.0003444855,0.003974024,0.00007820259,0.0006293545,0.01548806],"study_design_scores_gemma":[0.9096491,0.08242974,0.005748095,0.00003253137,0.0006233294,0.00007013386,0.00003810135,0.0002821388,0.0005020105,0.00009403833,0.0005077673,0.0000230493],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911314,0.00578133,0.0003230999,0.0006045421,0.0002873159,0.0004782437,0.0004965489,0.00004842301,0.0008491281],"genre_scores_gemma":[0.9924664,0.002666819,0.0006454545,0.000895204,0.0002721167,0.0004932119,0.0008758609,0.00002149425,0.001663369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003271954,"threshold_uncertainty_score":0.01166767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01426850573932332,"score_gpt":0.2623249024482707,"score_spread":0.2480563967089474,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}